Literature DB >> 110446

American experience with carminomycin.

L H Baker, D H Kessel, R L Comis, S D Reich, M D DeFuria, S T Crooke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 110446

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  5 in total

1.  Plasma kinetics of aclacinomycin A and its major metabolites in man.

Authors:  M J Egorin; D Van Echo; B M Fox; M Whitacre; N R Bachur
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 2.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

3.  Phase II study of carminomycin in a human tumor cloning assay.

Authors:  M Rozencweig; C Sanders; W Rombaut; N Crespeigne; G Decoster; Y Kenis; J Klastersky
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

4.  Pharmacokinetics of carminomycin in dogs and humans. Preliminary report.

Authors:  S D Reich; S E Fandrich; T T Finkelstein; J E Schurig; A P Florczyk; R L Comis; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

5.  Pharmacokinetics of anthracyclines in dogs: evidence for structure-related body distribution and reduction to their hydroxy metabolites.

Authors:  M J Oosterbaan; R J Dirks; T B Vree; E van der Kleijn
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.